Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 14/20 | 0.46 |
| ▸ | CHRNB2 | P17787 | 3/20 | 0.44 |
| ▸ | CHRNB4 | P30926 | 3/20 | 0.44 |
| ▸ | CHRNA3 | P32297 | 3/20 | 0.44 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.44 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL3132581 | 0.91 | ACHE (0.40) | ACHECHRNB2CHRNB4CHRNA3CHRNA4 | |
| Methacrylic Acid SCHEMBL630757 | 0.91 | ACHE (0.40) | ACHECHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL19199362 | 0.91 | CHRNB2 (0.45) | ACHECHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL10405560 | 0.89 | ACHE (0.38) | ACHECHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL3132587 | 0.89 | ACHE (0.38) | ACHECHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL472550 | 0.89 | ACHE (0.38) | ACHECHRNB2CHRNB4CHRNA3CHRNA4 | |
| 1,6-Hexanediol SCHEMBL4094908 | 0.88 | ACHE (0.40) | ACHECHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL3652808 | 0.88 | ACHE (0.37) | ACHECHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL25144063 | 0.88 | ACHE (0.36) | ACHECHRNB2CHRNB4CHRNA3CHRNA4 | |
| SCHEMBL19827588 | 0.87 | CHRNB2 (0.38) | ACHECHRNB2CHRNB4CHRNA3CHRNA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117794497-A | Monomer mixture for preparing dental materials | 穆尔鲍尔科技公司 | 2024-03-29 | — | — | CN | claimed |
| EP-4680181-A1 | MIXTURE, POLYMER, DENTAL POLYMER FOR 3D PRINTING AND MEDICAL PRODUCT THEREOF | PRO3DURE MEDICAL GMBH (DE) | 2026-01-21 | — | — | EP | disclosed |
| EP-4461256-A1 | DENTAL PROSTHESIS AND METHOD FOR PRODUCING A DENTAL PROSTHESIS | Klinkenberg, Veit (DE) | 2024-11-13 | — | — | EP | disclosed |
| WO-2024189111-A1 | MIXTURE, POLYMER, DENTAL POLYMER FOR 3D PRINTING AND MEDICAL PRODUCT THEREOF | Pro3dure Medical GmbH (DE) | 2024-09-19 | — | — | WO | disclosed |
| US-11992538-B2 | Polymerizable dental composition based on condensed silanes | VOCO GMBH (DE) | 2024-05-28 | — | — | US | disclosed |
| CN-117794497-A | Monomer mixture for preparing dental materials | 穆尔鲍尔科技公司 | 2024-03-29 | — | — | CN | disclosed |
| WO-2017132463-A1 | SURFACE PRIMER COMPOSITIONS AND METHODS OF USE | ACatechol, Inc. (US) | 2017-08-03 | — | — | WO | disclosed |
| EP-2598101-A1 | KIT OF PARTS, METHOD OF PRODUCING AND USE THEREOF | 3M Innovative Properties Company (US) | 2013-06-05 | — | — | EP | disclosed |
| WO-2012015814-A1 | KIT OF PARTS, METHOD OF PRODUCING AND USE THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2012-02-02 | — | — | WO | disclosed |
| US-20110081627-A1 | Methods for making provisional and long-term dental crowns and bridges | SUN BENJAMIN JIEMIN | 2011-04-07 | — | — | US | disclosed |
| US-20080085493-A1 | Methods for making provisional and long-term dental crowns and bridges | SUN BENJAMIN J | 2008-04-10 | — | — | US | disclosed |
| EP-0047971-A1 | Mineral particles, process for their preparation and dental materials containing them | DMG - Dental-Material-Gesellschaft mbH (DE) | 1982-03-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11992538-B2 | Polymerizable dental composition based on condensed silanes | NCAPH, RCC1, NCAPD2 | ACHE 3835/4885CHRNB2 2573/4885CHRNB4 2704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.